Atlas Trials

Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments

Clinical trial NCT01365559 · COMPLETED

Trial details

NCT number
NCT01365559
Sponsor
Oncotherapeutics
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2011-05-02
Primary completion
2014-06-13
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.